Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.92% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.35% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Quad
QUAD
$479M
| $10.2M | 0.02% |
790,000
+319,700
| +68% | +$3.46M |
|
|
WNR
1127
DELISTED
Western Refining Inc
WNR
| $10.2M | 0.02% |
351,100
-210,200
| -37% | -$6.34M |
|
|
BEAT
1128
DELISTED
BioTelemetry, Inc.
BEAT
| $10.2M | 0.02% |
873,900
+54,300
| +7% | +$607K |
|
|
SHLX
1129
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $10.2M | 0.02% |
+278,343
| New | +$9.81M |
|
1130
Pacific Biosciences
PACB
$435M
| $10.1M | 0.02% |
1,188,700
-397,700
| -25% | -$3.91M |
|
|
CHMT
1131
DELISTED
Chemtura Corporation
CHMT
| $10M | 0.02% |
380,068
-172,900
| -31% | -$4.42M |
|
|
CHSP
1132
DELISTED
Chesapeake Lodging Trust
CHSP
| $10M | 0.02% |
378,600
+135,800
| +56% | +$3.42M |
|
|
HMHC
1133
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $9.99M | 0.02% |
500,800
+285,000
| +132% | +$5.25M |
|
1134
Roper Technologies
ROP
$40.4B
| $9.94M | 0.02% |
+54,400
| New | +$9.37M |
|
|
ARC
1135
DELISTED
ARC Document Solutions, Inc.
ARC
| $9.94M | 0.02% |
2,208,800
+325,000
| +17% | +$1.22M |
|
|
JIVE
1136
DELISTED
Jive Software, Inc.
JIVE
| $9.94M | 0.02% |
2,629,300
+118,800
| +5% | +$413K |
|
1137
T. Rowe Price
TROW
$25.5B
| $9.93M | 0.02% |
135,200
-128,000
| -49% | -$8.89M |
|
1138
Deluxe
DLX
$1.25B
| $9.93M | 0.02% |
158,900
+108,000
| +212% | +$6.02M |
|
|
RATE
1139
DELISTED
Bankrate Inc
RATE
| $9.91M | 0.02% |
1,080,400
+681,100
| +171% | +$7.11M |
|
|
CLVS
1140
DELISTED
Clovis Oncology, Inc.
CLVS
| $9.9M | 0.02% |
+515,400
| New | +$10.9M |
|
1141
AMC Entertainment Holdings
AMC
$2.45B
| $9.89M | 0.02% |
35,320
+1,070
| +3% | +$256K |
|
|
PFSW
1142
DELISTED
PFSweb, Inc.
PFSW
| $9.88M | 0.02% |
752,939
-276,900
| -27% | -$3.43M |
|
1143
Bio-Techne
TECH
$11.2B
| $9.84M | 0.02% |
416,400
-222,800
| -35% | -$4.91M |
|
|
SAND
1144
DELISTED
Sandstorm Gold
SAND
| $9.83M | 0.02% |
2,989,245
+1,052,045
| +54% | +$2.9M |
|
|
HPP
1145
Hudson Pacific Properties
HPP
$758M
| $9.83M | 0.02% |
48,557
-3,721
| -7% | -$676K |
|
|
HOT
1146
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $9.83M | 0.02% |
117,800
-936,100
| -89% | -$63.9M |
|
|
AEGN
1147
DELISTED
Aegion Corp
AEGN
| $9.83M | 0.02% |
465,896
+145,096
| +45% | +$2.71M |
|
1148
MGIC Investment
MTG
$6.47B
| $9.82M | 0.02% |
1,280,800
-1,891,800
| -60% | -$13.6M |
|
|
ZVO
1149
DELISTED
Zovio Inc. Common Stock
ZVO
| $9.8M | 0.02% |
972,258
+184,448
| +23% | +$1.4M |
|
1150
Silicon Laboratories
SLAB
$7.14B
| $9.8M | 0.02% |
+217,898
| New | +$9.37M |
|
Similar funds
Renaissance Technologies's Q1 2016 Portfolio in Review
As of Q1 2016, Renaissance Technologies held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Renaissance Technologies's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Renaissance Technologies added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Renaissance Technologies's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Renaissance Technologies fully exited Apple in Q1 2016, selling an estimated $470M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Renaissance Technologies opened 498 new positions and closed 403 in Q1 2016.
- Renaissance Technologies's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.